Aptadir Therapeutics
- Website
- aptadir.com
- Total Funding
- $45.0M
- Last Round
- $45.0M SeedSep 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Aptadir Therapeutics develops an RNA-based therapeutic platform for untreatable cancers and rare diseases. The platform enables selective inhibition of DNMT1 through global and locus-specific approaches. Modified short RNA oligonucleotides support global inhibition, while combining them with a gene-specific sequence allows targeting of a particular locus. Its approach builds on the discovery that specific RNAs bind to and inhibit DNMT1.
Summary
Aptadir Therapeutics is a Biotech company. It has raised $45.0M in total across 1 round, most recently a $45.0M Seed round in Sep 2026.
Funding History
Sep 2026
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aptadir-therapeutics"><img src="https://indexed.vc/api/badge/company/aptadir-therapeutics" alt="Aptadir Therapeutics on Indexed.vc" width="260" height="76" /></a>